Companion Diagnostics Market Research Reports & Industry Analysis
The companion diagnostics market is one of the fastest growing segments of the IVD and clinical lab services markets. In the United States, over half of all FDA approvals for companion diagnostics have occurred since 2010. The closely associated pharmacodiagnostics IVD market is expected to grow annually by over 20%. The wild success of reference laboratories in the companion diagnostics market even prompted the unprecedented expansion of FDA oversight over laboratory developed tests (LDTs).
Companion diagnostics are increasingly integral to the approval of some new pharmaceuticals, illustrating which individuals are most likely to benefit from the drug. With the approval of CDx-assisted therapies, new high-growth markets are opened for lab tests and IVD products.
Companion diagnostics (CDx) include in vivo or medical imaging procedures and in vitro diagnostic (IVD) lab tests used to determine the efficacy of a particular therapy, most commonly pharmaceutical. Genome research in recent decades has illuminated and detailed the role genetics play in drug metabolism and disease etiology. Drugs can now be paired with IVD and medical imaging tests for prescription decisions and therapeutic monitoring. In vitro companion diagnostics are largely molecular assays, though additional formats include immunohistochemistry (IHC) and immunoassays, and are offered as test kits, analyte specific reagents, and laboratory developed tests (LDTs) or a lab testing service.
The majority of companion diagnostics are pharmacodiagnostic lab tests used to assess an individual’s response to drug therapy. Pharmacodiagnostics represents a major front in a healthcare system-wide push towards personalized medicine. Pharmacodiagnostic tests can be used to determine patient response to clopidogrel anticoagulant drugs, appropriate drug dosage, and the prescription of oncology drugs based on genetic markers.
Stay abreast of fast-paced and promising companion diagnostics markets with MarketResearch.com’s collection of market research studies. We offer a wide selection of studies treating companion diagnostic regulation, regional and disease-specific market development, product and test pipelines, and companion diagnostic product market tracking.
Companion Diagnostics Industry Research & Market Reports
-
2023 Global Forecast for Companion Diagnostics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales (product ... Read More
-
2023 Global Forecast for Companion Animal Diagnostics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales ... Read More
-
Global Fluorescent in Situ Hybridization (FISH) Probe Market: Analysis By Product (Instrument/ Software And Consumables), By Technology (Q FISH, Flow FISH And Others), By End User (Clinical Procedures, Research And Companion Diagnostics), By Application (Cancer Diagnostics And Other), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2027
... Diagnostics And Other), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2027 The global fluorescent in situ hybridization (FISH) probe market in 2021 was valued at US$1.40 billion. The market ... Read More
-
Cancer Diagnostics Oncology Companion Diagnostics Market Research Report 2022-2030
... growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Cancer Diagnostics Oncology Companion ... Read More
-
In Situ Hybridization Market by Products (Consumables, Instruments, Software), Technology (DNA FISH, RNA FISH, PNA FISH, CISH), Application (Cancer, Immunology, Neuroscience, Cytology), End User (Hospitals, Pharma, Biotech, CROs) – Global Forecast to 2027
... in situ hybridization market is projected to reach USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 12.6% during the forecast period. Companion diagnostic products showcase a significant potential ... Read More
-
Companion Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)
... during the forecast period (2022-2027). Early diagnosis of COVID-19 is becoming essential in the market, as it can help find the right treatment for patients impacted by the virus. The most commonly used and reliable ... Read More
-
Companion Diagnostics for Oncology Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Companion Diagnostics for Oncology market size is growing at a ... Read More
-
Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
... 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of ... Read More
-
Indonesia In-Vitro Diagnostics Market Research Report Forecast to 2027
... body to help detect infection, diagnose a medical condition, and prevent disease. IVD plays a major role in the early diagnosis and management of diseases. The key factors that drive the Indonesia in-vitro diagnostics market ... Read More
-
Middle East And Africa Companion Diagnostics Market 2022-2028
... 12.53% during the forecast years 2022-2028. Israel, South Africa, the UAE, Saudi Arabia, Turkey, and Rest of Middle East & Africa are studied in the given region. Over the years, precision medicine has gained significant ... Read More
-
North America Companion Diagnostics Market 2022-2028
... 2022 to 2028. The United States and Canada shape the market in the region. In Canada, several public and private initiatives are expected to widen the scope of the studied market, despite limited healthcare policy. ... Read More
-
Asia-pacific Companion Diagnostics Market 2022-2028
... Zealand, Japan, ASEAN countries, South Korea, and Rest of Asia-Pacific are considered in the region. India is considered a major emerging genomics market, with oncologists accepting biomarker-based tests. The rising middle-class healthcare facilities and skilled ... Read More
-
Europe Companion Diagnostics Market 2022-2028
... Italy, Spain, France, Germany, Poland, the United Kingdom, and the Rest of Europe are evaluated in the market report. In France, the majority of the population is supported by statutory health insurance overseen by the ... Read More
-
Latin America Companion Diagnostics Market 2022-2028
... years 2022-2028. Mexico, Brazil, and Rest of Latin America are considered in the region. In Mexico, initiatives undertaken to reduce approval time for clinical trials are anticipated to surge the adoption of companion diagnostics devices. ... Read More
-
Global Companion Diagnostics Market 2022-2028
... fueling the global market’s growth include a surge in medication reaction incidence, increasing cancer cases, and the growing use of precision medicines. Additionally, the ongoing research and investments in next generation gene-sequencing are expected to ... Read More
-
The Worldwide Market for In Vitro Diagnostic Tests, 15th Edition
... state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights ... Read More
-
Global Oncology Companion Diagnostics Market 2022-2028
... 13.6% during 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global oncology companion diagnostics market. It offers an exclusive insight into various details such ... Read More
-
India Companion Diagnostics Market Forecast 2022-2028
... is 2021, the forecasting years are from 2022 to 2028. The market growth of the country is fueled by the rise in middle-class healthcare facilities as well as the rapidly developing genomics industry. MARKET INSIGHTS ... Read More
-
Global Companion Diagnostics Market Forecast 2022-2030
... rising number of cancer cases and mortalities, the increasing number of adverse drug reaction cases, and the growing popularity of precision medicines. MARKET INSIGHTS Companion diagnostics provide crucial data for patient classification, facilitating the effective ... Read More
-
Asia-pacific Companion Diagnostics Market Forecast 2022-2030
... in healthcare awareness, collaborations between diagnostic companies, the pharmaceutical industry, regulatory authorities, and service providers to provide an international platform, and the significant development in precision medicine technology are primarily ascribed to the region’s market ... Read More
-
North America Companion Diagnostics Market Forecast 2022-2030
... incidence of neurodegenerative conditions, including Alzheimer’s disease, the growing prevalence of chronic diseases, intensifying health consciousness, and the rollout of healthcare plans by the government are among the key factors contributing to the market growth ... Read More
-
Europe Companion Diagnostics Market Forecast 2022-2030
... market’s growth include the increasing focus on collaborative research and development towards advancing precision medicine technologies and the surging need for technologically advanced medical diagnostics. MARKET INSIGHTS The Europe companion diagnostics market growth evaluation encompasses ... Read More
-
Precision Medicine Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
... and senior management with the critical information they need to assess the global precision medicine market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Companion Diagnostics Market Analysis and Forecast to 2031: By Product & Services (Assays, Kits & Reagents, Software & Services), Technology (Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry, Others), Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), and Region
... Diseases, Infectious Diseases, Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), and Region The global companion diagnostics market was valued at USD 5.9 billion in 2021 and it is anticipated ... Read More
-
Global Oncology Companion Diagnostics Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). A test that determines whether a patient is a good candidate for a particular drug or therapy. A companion diagnostic test, for instance, could ... Read More
Research Assistance
